Nektar Therapeutics (NKTR) Hedge Fund Ownership (Q2 2026)

Nektar Therapeutics (NKTR)

236 + Investors. Track Smart Money conviction in NKTR. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — NKTR

Based on 240 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q

For 4 consecutive quarters, more hedge funds added NKTR than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

240 hedge funds hold NKTR right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +120% more funds vs a year ago

fund count last 6Q

+131 new funds entered over the past year (+120% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks. The peak was reached in just 4 quarters from the low — a sharp move.

🟢

More buyers than sellers — 65% buying

176 buying93 selling

Last quarter: 176 funds were net buyers (73 opened a brand new position + 103 added to an existing one). Only 93 were sellers (45 trimmed + 48 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~73 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 63 → 65 → 71 → 73. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

51% of holders stayed for 2+ years

■ 51% conviction (2yr+) ■ 18% medium ■ 30% new

123 out of 240 hedge funds have held NKTR for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

📈

Growing discovery — still being found

28 → 63 → 65 → 71 → 73 new funds/Q

New funds entering each quarter: 63 → 65 → 71 → 73. A growing number of institutions are discovering NKTR each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🏛️

Veteran-anchored — 58% veterans vs 33% newcomers

■ 58% veterans ■ 9% 1-2yr ■ 33% new

Entry-cohort mix of 253 holders: 146 (58%) are 2+ year veterans, 23 entered 1–2 years ago, and 84 (33%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

🏆

Elite ownership — 44% AUM from top-100 funds

44% from top-100 AUM funds

43 of 237 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in NKTR. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

4.9

out of 10

Moderate Exit Risk

Exit risk score 4.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	236	215	9.77%
13F Shares	38M	28M	34.32%
Total Value	$2.60B	$1.98B	31.42%
New Positions	73	71	+2
Increased Positions	99	75	+24
Closed Positions	49	37	+12
Reduced Positions	42	49	-7
Total Calls	9	7	28.57%
Total Puts	7	5	40.0%
PUT/CALL Ratio	0.78	0.71	Neutral

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

236

215

9.77%

13F Shares

38M

28M

34.32%

Total Value

$2.60B

$1.98B

31.42%

New Positions

Increased Positions

+24

Closed Positions

+12

Reduced Positions

-7

Total Calls

28.57%

Total Puts

40.0%

PUT/CALL Ratio

0.78

0.71

Neutral

Institutional Holders (2026 Q2)

236 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NKTR. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 NKTR holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	22nw, LP	18.75%	281,115	$19.6M
2	Prosight Management, LP	9.74%	810,000	$56.5M
3	Creek Drive Management Group LLC	8.24%	243,000	$17.0M
4	APEIRON CAPITAL Ltd	4.77%	106,431	$7.4M
5	Two Seas Capital LP	4.28%	3,092,234	$215.9M
6	Bvf Inc/Il	4.27%	2,391,075	$166.9M
7	DAFNA Capital Management LLC	4.24%	318,380	$22.2M
8	Act Capital Management, LLC	4.07%	89,300	$6.2M
9	Stonepine Capital Management, LLC	3.94%	120,654	$8.4M
10	Birchview Capital, LP	2.64%	81,000	$5.7M
11	Great Point Partners LLC	2.31%	175,000	$12.2M
12	Sofinnova Investments, Inc.	1.70%	471,763	$32.9M
13	Vestal Point Capital, LP	1.63%	1,000,000	$69.8M
14	Bronte Capital Management Pty Ltd.	1.49%	198,434	$13.9M
15	KVP Capital Advisors, LP	1.38%	26,900	$1.9M
16	Ishara Investments LP	1.37%	26,650	$1.9M
17	Braidwell LP	1.22%	473,617	$33.1M
18	Exome Asset Management LLC	0.97%	22,417	$1.6M
19	Tetragon Partners GP Ltd	0.96%	86,996	$6.1M
20	Rhenman & Partners Asset Management AB	0.93%	141,250	$9.9M
21	Iridian Asset Management LLC/Ct	0.93%	38,802	$2.7M
22	Moody Aldrich Partners LLC	0.80%	64,135	$4.5M
23	ADAR1 Capital Management, LLC	0.78%	244,184	$17.0M
24	Seven Grand Managers, LLC	0.67%	240,000	$16.8M
25	Emerald Advisers, LLC	0.64%	390,158	$27.2M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Nektar Therapeutics (NKTR)

What does the Smart Money Trend signal show for NKTR?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added NKTR than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for NKTR?

More buyers than sellers — 65% buying: Last quarter: 176 funds were net buyers (73 opened a brand new position + 103 added to an existing one). Only 93 were sellers (45 trimmed + 48 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for NKTR holders?

Elite ownership — 44% AUM from top-100 funds: 43 of 237 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in NKTR. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held NKTR?

51% of holders stayed for 2+ years: 123 out of 240 hedge funds have held NKTR for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Nektar Therapeutics (NKTR)

Smart Money Signals — NKTR

Buying streak — 4 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +120% more funds vs a year ago

More buyers than sellers — 65% buying

Steady new buyers — ~73 new funds per quarter

51% of holders stayed for 2+ years

Growing discovery — still being found

Veteran-anchored — 58% veterans vs 33% newcomers

Elite ownership — 44% AUM from top-100 funds

Institutional Sentiment Summary — NKTR

Hedge Fund Ownership: NKTR

Market Analysis: NKTR

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: NKTR

Hedge Fund Positioning: NKTR

Statistics: NKTR

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Nektar Therapeutics (NKTR)

Welcome to 13Foresight!